D5Pharma’s groundbreaking new cancer vaccine, MetVax, capitalizes on a precisely defined protein fragment of carcinoembryonic antigen—a well-established mediator of adhesion and tumor implantation— to block metastasis.
![](https://www.d5pharma.com/wp-content/uploads/cea.jpg)
D5Pharma’s groundbreaking new cancer vaccine, MetVax, capitalizes on a precisely defined protein fragment of carcinoembryonic antigen—a well-established mediator of adhesion and tumor implantation— to block metastasis.